Body and Mind Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - April 10, 2026) - Body and Mind Inc. (CSE: BAMM) (the "Company" or "BaM") is pleased to announce that it has closed the Illinois dispensary transactions, which it had previously disclosed in a news release dated January 30, 2025. NMG IL 4 Transaction: DEP Nevada, Inc. received $833,333 in cash less $43,831.56 for certain indebtedness of NMG IL 4 immediately prior to closing and transaction expenses. The transaction also
2026-04-10 11:38 AM EDT | Body and Mind Inc.
Stock Trend Capital Provides Younet AI Investment Update
Vancouver, British Columbia--(Newsfile Corp. - April 10, 2026) - Stock Trend Capital Inc. (CSE: STCQ) (FSE: P0G) (OTC Pink: STOCF) (the "Company" or "Stock Trend"), is pleased to provide shareholders with an update regarding its investment in Younet AI ("Younet"). In connection with this update, the Company is providing Younet's most recent news release, reproduced in full below. Younet AI Partners with Perpetuals.com to L
Technology, Internet Technology, Cannabis
2026-04-10 7:30 AM EDT | Stock Trend Capital Inc.
Akanda Corp. Announces Reverse Stock Split
Toronto, Ontario--(Newsfile Corp. - April 9, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it expects to implement a 1-for-4.5 reverse stock split of the Company's common shares effective April 13, 2026. The reverse stock split was previously approved by the Company's shareholders on November 28, 2025 and Board of Directors on March 23, 2026 and will begin trading on an adjusted basis giving effect to the reverse stock split at the opening of market on
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-04-09 8:30 AM EDT | Akanda Corp
FloraWorks Announces TruCBN(TM) Readiness for the CMS Substance Access BEI Program with Full Clinical and Safety Substantiation
Portland, Oregon--(Newsfile Corp. - April 9, 2026) - FloraWorks today announced that TruCBN™ 50 mg softgels are available to healthcare organizations evaluating sleep-focused hemp products for the CMS Substance Access Beneficiary Engagement Incentive (BEI) program. In a published 1,020-person randomized, double-blind, placebo-controlled clinical trial, TruCBN™ 50 mg dose demonstrated statistically significant improvement in sleep quality. Real-world evidence has
Technology, Cannabis, Health, Cannabis Manufacturer
2026-04-09 8:00 AM EDT | FloraWorks
Digicann Ventures Announces Resignation of Director
Vancouver, British Columbia--(Newsfile Corp. - April 8, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis industry, announces that Jordan Fogle has resigned from the Board of Directors, effective immediately. Mr. Fogle has indicated that his current professional obligations require his full attention, which preclude him from continuing in his role as an independent director of the
Banking / Financial Services, Cannabis
2026-04-08 5:30 PM EDT | Digicann Ventures Inc.
Akanda Adjourns Shareholder Meeting
Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announced that on March 31, 2026, it convened and subsequently adjourned its Special Meeting of Shareholders (the "Meeting") without transacting any business due to the absence of a quorum. The Meeting has been adjourned and will be reconvened in person in Toronto, Ontario on Monday, April 27, 2026 at 10:00 a.m. (Eastern Time). The adjournment provides
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-04-07 8:30 AM EDT | Akanda Corp
Red Light Holland Reports Continued Expansion of Filament Health's PEX010 Clinical Network with New License Agreements and Research Shipments
Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") today announced that Filament Health Corp. ("Filament") signed three new license agreements and completed two research shipments during March 2026, further expanding the global cl
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-04-07 7:30 AM EDT | Red Light Holland Corp.
Simply Solventless Provides Restructuring Update, Including Expected Timing, and Announces Management Change
Calgary, Alberta--(Newsfile Corp. - April 6, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") is pleased to provide an update regarding the previously announced restructuring of Massive Hash Factory Ltd. ("MHF"), CannMart Inc. ("CannMart"), and ANC Inc. ("ANC") (and collectively with MHF and CannMart, the "CCAA Appl
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2026-04-06 6:00 AM EDT | Simply Solventless Concentrates Ltd.
Red Light Holland to Support University of California San Francisco's Global Psychedelic Study Through Filament Health's Clinical Network
Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") today announced that, through Filament Health Corp. ("Filament"), it will support the Carhart-Harris Lab ("CHL") at the University of California, San Francisco ("UCSF") by providing instructions on how to participate in the CHL Global Psychedelic Study to all researchers and clinicians receiving PEX010, including clinical trials and compassionate us
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-04-01 9:20 AM EDT | Red Light Holland Corp.
Cardiol Therapeutics Announces Year-End 2025 Update on Operations
Initiated pivotal Phase III MAVERIC trial of CardiolRx™ in recurrent pericarditis and surpassed 50% patient enrollment, with full enrollment expected in Q2 2026. Reported positive Phase II ARCHER data showing CardiolRx™ significantly reduced left ventricular mass in patients with acute myocarditis; results published in ESC Heart Failure. Advanced CRD-38 program, a novel next generation drug intended for use in heart failure an
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-04-01 7:27 AM EDT | Cardiol Therapeutics Inc.
City View Investee Company ArkenYield Secures Circle Alliance Partnership
Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - City View Green Holdings Inc. (CSE: CVGR) (OTCID: CVGRF) (FSE: CVY0) (the "Company" or "City View"), announces that its investee company ArkenYield, a builder of stablecoin liquidity and yield infrastructure, has joined the Circle Alliance Program, positioning the Company among a select group of infrastructure providers and fintech platforms building directly with USDC. This milestone places ArkenYield alongside leading participants i
Food / Beverages, Cannabis, Cannabis Extractor, Cannabis Manufacturer
2026-04-01 6:30 AM EDT | City View Green Holdings Inc.
Captiva Verde Welcomes Josh F.W. Cook to the Advisory Board
Jacksonville, Florida--(Newsfile Corp. - March 30, 2026) - Captiva Verde Corp. (CSE: PWR) (OTC Pink: CPIVF) (the "Company or Captiva") announces the appointment of Josh F.W. Cook to the Advisory Board. Josh F.W. Cook is a seasoned government executive and communications consultant with over 30 years of experience solving complex political and natural resource conflicts in California, Arizona, and Nevada. Josh most recently served as EPA Administrator for R
Agriculture, Cannabis, Cannabis Manufacturer
2026-03-30 9:00 AM EDT | Captiva Verde Wellness Corp.
Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion
Strategic closure and planned sale of Eloy cultivation facility expected to improve Arizona profitability and enhance free cash flow. Proceeds from the sale to facilitate debt reduction, with key equipment redeployed to the Ohio market, saving approximately $2 million in capital expenditures to support Vext's build-out in the State. Plans to seek approval to expand Jackson cultivation to support a growing retail footprint a
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2026-03-30 7:30 AM EDT | VEXT Science, Inc.
Akanda Corp. Driving Recurring Revenue Growth: $2 Million Cash Flow Secured Through Fiber Acquisition
Toronto, Ontario--(Newsfile Corp. - March 26, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its wholly owned subsidiary, First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, are pleased to announce an expansion of its dark fiber network with the addition of approximately 200 kilometres, increasing total network coverage to approximately 900 kilometres across Central Mexico. This milestone is expected to material
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-03-26 8:30 AM EDT | Akanda Corp
Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement
Toronto, Ontario--(Newsfile Corp. - March 23, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Filament Health Corp. (OTC: FLHLF) ("Filament") today announced that, further to the joint press release dated March 10, 2026, the Supreme Court of British Columbia issued an interim order (the "Interim Order") in connection with the previously announced acquisition by Red Light of all the issued and outstandin
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-03-23 8:15 AM EDT | Red Light Holland Corp.
Psyched Wellness Announces Closing of Private Placement and Shares for Debt Transaction and Resignation of a Director
Toronto, Ontario--(Newsfile Corp. - March 20, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces the closing of (i) the first tranche of its non-brokered private placement (the "Offering") for gross proceeds of C$859,653.47, led by Gotham Green Fund III, L.P. and Gotham Green Fund III (Q), L.P. (together with the
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-03-20 9:16 AM EDT | Psyched Wellness Ltd.
Delivra Health Brands Launches Dream Water(R) Kids Sleep Gummies in the United States Market
Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its Dream Water® brand is launching its new Dream Water Kids Sleep Gummies in the US market. Dream Water Kids Sleep Gummies are expected to be available to Company distributors, retailers and e-c
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2026-03-19 5:30 PM EDT | Delivra Health Brands Inc.
City View Announces Filing of Change of Business Documents with the CSE
Toronto, Ontario--(Newsfile Corp. - March 19, 2026) - City View Green Holdings Inc. (CSE: CVGR) (OTCID: CVGRF) (FSE: CVY0) (the "Company" or "City View") announces that it has filed the necessary Form 2A Listing Statement with the CSE providing full disclosure on the new business model in connection with its proposed change of business from an "industrial issuer" to an "investment issuer" (the "Proposed COB"). In connection with the Proposed COB and subject to CSE approval, the Company inten
Food / Beverages, Cannabis, Cannabis Extractor, Cannabis Manufacturer
2026-03-19 7:00 AM EDT | City View Green Holdings Inc.
Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate
Ontario and Arlington, Massachusetts--(Newsfile Corp. - March 18, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Kala Bio, Inc. (NASDAQ: KALA) ("Kala Bio") today announced that Red Li
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-03-18 8:15 AM EDT | Red Light Holland Corp.
PharmaCielo Announces the Issuance of Interest Shares
Ontario and Rionegro, Colombia--(Newsfile Corp. - March 17, 2026) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that, as approved by the TSX
2026-03-17 7:30 AM EDT | PharmaCielo Ltd.